Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 736 to 750 of 1559 results for do not do recommendations

  1. Romiplostim for the treatment of chronic immune thrombocytopenia (TA221)

    Evidence-based recommendations on romiplostim (Nplate) for treating chronic immune thrombocytopenia in adults.

    Technology appraisal guidance
    Last updated
    26 October 2018
    View recommendations

    Sections for TA221

  2. Characteristics of a person delivering an intervention:- How do the professional characteristics of pharmacy staff affect the effectiveness and cost effectiveness of delivering information, advice, education or behavioural support to underserved groups and the general population? (Characteristics include, for example, job roles such as health champion, as well as competencies and level of training.)

    Recommendation ID NG102/4 Question Characteristics of a person delivering an intervention:- How do the professional...

    Research recommendation
    Published
    12 December 2018

  3. Support for transitions: What do children and young people, including those from underserved populations, find useful to support life changes in the context of their education?

    Recommendation ID NG223/10 Question Support for transitions: What do children and young people, including those from...

    Research recommendation
    Published
    4 August 2022

  4. What are the most effective and cost-effective population-level measures to help people in mid-life maintain or adopt healthy behaviours and build up resilience to dementia, disability and frailty? What are the best methods for evaluating their effect? How do these measures affect health inequalities?

    Recommendation ID NG16/2 Question What are the most effective and cost-effective population-level measures to help people in mid-life...

    Research recommendation
    Published
    9 December 2015

  5. Individual circumstances and the risk of dependence: Do individual circumstances such as social distress, low income or limited access to alternative sources of support lead to an increased risk of problems associated with dependence on prescribed medicines?

    Recommendation ID NG215/04 Question Individual circumstances and the risk of dependence: Do individual circumstances such...

    Research recommendation
    Published
    11 May 2022

  6. System-level factors and the risk of dependence: Do system-level factors, such as training received by prescribers alter the risk of developing problems associated with dependence on prescribed medicines?

    Recommendation ID NG215/06 Question System-level factors and the risk of dependence: Do system-level factors, such as...

    Research recommendation
    Published
    11 May 2022

  7. Practitioners and providers' awareness of risk in black, Asian and other minority ethnic groups: Are clinicians, practitioners and weight management service providers aware that black, Asian and other minority ethnic groups are at the same risk of type 2 diabetes and mortality at a lower BMI compared with the white population. If so, do they intervene at lower BMI and waist-to-height ratio thresholds?

    Recommendation ID CG189/11 Question Practitioners and providers' awareness of risk in black, Asian and other minority ethnic groups: Are

    Research recommendation
    Published
    30 September 2022

  8. How effective and cost effective are different types of intervention to prevent a range of cold-related illnesses and death? How do these vary with groups in different circumstances?

    Recommendation ID NG6/3 Question How effective and cost effective are different types of intervention to prevent a range of cold-related

    Research recommendation
    Published
    9 June 2015

  9. Avatrombopag for treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA626)

    Evidence-based recommendations on avatrombopag (Doptelet) for treating severe thrombocytopenia in adults with chronic liver disease needing a planned invasive procedure.

    Technology appraisal guidance
    Published
    24 June 2020
    View recommendations

    Sections for TA626

  10. Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome (HST31)

    Evidence-based recommendations on setmelanotide (Imcivree) for treating obesity and hyperphagia in Bardet-Biedl syndrome in people 6 years and over, only if they are between 6 and 17 years when treatment starts.

    Highly specialised technologies guidance
    Published
    22 May 2024
    View recommendations

    Sections for HST31

  11. Reducing demands on health and social care services:- Do preventive oral health interventions in residential and nursing care homes reduce demands on other health and social care services?

    Recommendation ID NG48/5 Question Reducing demands on health and social care services:- Do preventive oral health...

    Research recommendation
    Published
    24 August 2016

  12. Uterine artery embolisation for treating adenomyosis (HTG324)

    Evidence-based recommendations on uterine artery embolisation for treating adenomyosis. This involves injecting small particles to block the blood supply to the adenomyosis (thickening of the womb lining).

    HealthTech guidance
    Published
    16 December 2013
    View recommendations

    Sections for HTG324

  13. Transcutaneous microwave ablation for severe primary axillary hyperhidrosis (HTG458)

    Evidence-based recommendations on transcutaneous microwave ablation for severe primary axillary hyperhidrosis in adults. This involves using microwaves to destroy sweat glands in the armpit.

    HealthTech guidance
    Published
    20 December 2017
    View recommendations

    Sections for HTG458

  14. Intermittent urethral catheters for chronic incomplete bladder emptying in adults: late-stage assessment (HTG753)

    Late-stage assessment (LSA) guidance on intermittent urethral catheters for chronic incomplete bladder emptying in adults.

    HealthTech guidance
    Published
    9 July 2025
    View recommendations

    Sections for HTG753

  15. What interventions are effective to support medicines adherence for people with complex psychosis in supported accommodation?

    Recommendation ID NG181/9 Question What interventions are effective to support medicines adherence for people with complex psychosis in

    Research recommendation
    Published
    26 October 2020